Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
5.17
+0.04 (0.78%)
At close: Aug 4, 2026
Starling Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 517 | 350 | 23 | 150 | 123 | 714 | |
Market Cap Growth | 53.67% | 1400.09% | -84.48% | 22.52% | -82.81% | - |
Enterprise Value | 598 | 426 | 99 | 181 | 139 | 808 |
Last Close Price | 5.24 | 3.56 | 0.31 | 2.04 | 1.65 | 9.75 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 1805.81 | - |
PS Ratio | 0.96 | 0.70 | 0.06 | 0.46 | 0.49 | 3.52 |
PB Ratio | - | -22.28 | 6.51 | 2.64 | 1.00 | 6.86 |
P/TBV Ratio | - | - | - | 4.72 | 1.47 | 12.05 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.10 | 0.85 | 0.25 | 0.56 | 0.55 | 3.98 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -6.44 | -6.60 | 34.31 | 2.10 | 0.88 | 0.00 |
Net Debt / Equity Ratio | -4.58 | -4.46 | 20.48 | 0.65 | 0.28 | -1.10 |
Net Debt / EBITDA Ratio | -2.88 | -2.41 | -1.36 | -0.68 | -0.51 | 2.71 |
Net Debt / FCF Ratio | -2.90 | -2.53 | -2.42 | -0.90 | -0.51 | 3.21 |
Asset Turnover | 3.29 | 2.98 | 2.06 | 1.38 | 1.09 | 1.51 |
Inventory Turnover | 25.32 | 31.68 | 28.62 | 23.08 | 25.53 | 30.05 |
Quick Ratio | 1.13 | 1.31 | 1.88 | 3.62 | 3.84 | 4.55 |
Current Ratio | 1.47 | 1.59 | 2.15 | 4.13 | 4.39 | 5.17 |
Return on Equity (ROE) | - | - | -213.36% | -92.20% | 0.13% | -16.52% |
Return on Assets (ROA) | -12.30% | -13.37% | -19.67% | -15.97% | -19.35% | -21.08% |
Return on Invested Capital (ROIC) | -35.80% | -42.26% | -70.35% | -47.85% | -97.58% | -377.00% |
Return on Capital Employed (ROCE) | -36.80% | -38.50% | -49.90% | -34.50% | -31.00% | -26.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -6.94% | -17.30% | -276.96% | -55.21% | 0.12% | -1.53% |
FCF Yield | -4.92% | -7.93% | -129.89% | -27.17% | -54.80% | -4.98% |
Buyback Yield / Dilution | -30.10% | -23.11% | -1.76% | 8.51% | -21.70% | -12.03% |